Single-center outcome analysis of 1,161 patients with St. Jude Medical and ATS Open Pivot mechanical heart valves

Journal of Heart Valve Disease

Volumn 16, Issue 2, 2007, Pages 151-158

  Bernet, Franziska H ^a   Baykut, Doan ^a   Grize, Leticia ^b   Zerkowski, Hans Reinhard ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; COMPARATIVE STUDY; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; MORTALITY; PATHOPHYSIOLOGY; POSTOPERATIVE HEMORRHAGE; PROSTHESIS; RETROSPECTIVE STUDY; SURVIVAL; SWITZERLAND; THROMBOSIS; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; ENDOCARDITIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; POSTOPERATIVE HEMORRHAGE; PROSTHESIS DESIGN; RESEARCH DESIGN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SWITZERLAND; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34347337803     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Emery RW, Mettler E, Nicoloff DM. A new cardiac prosthesis: The St. Jude Medical cardiac valve. In vivo results. Circulation 1979;60(Suppl.):48-54
2. Kulik A, Rubens FD, Wells PS, et al. Early postoperative anticoagulation after mechanical valve replacement: A systematic review. Ann Thorac Surg 2006;81:770-781 (Pubitemid 43120610)
3. Will MB, Bernacca GM, Bell EF, et al. Our inability to predict thromboembolic events after prosthetic valve surgery. J Heart Valve Dis 2006;15:570-580 (Pubitemid 44122693)
4. Grunkemeier GL, Li HH, Naftel IX, Starr A, Rahimtoola SH. Lon-term performance of heart valve prostheses. Curr Probl Cardiol 2000;25:75-154
5. Butchart EG, Ionescu A, Payne N, Giddings J, Grunkemeier GL, Fraser AG. A new scoring system to determine thromboembolic risk after heart valve replacement. Circulation 2003;108(Suppl.1):1168-1174
6. Herring D, Piper C, Bergemann R, et al. Thromboembolic and bleeding complications following St. Jude Medical valve replacement. Chest 2005;127; 53-59
7. Butchart EG, Payne N, Li HH, Buchan K, Mandana K, Grunkemeier GL. Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 2002;123:715-723 (Pubitemid 34535082)
8. Ikonomidis JS, Kratz JM, Crumbley AJ, et al. Twenty-year experience with the St. Jude Medical mechanical valve prosthesis. J Thorac Cardiovasc Surg 2003;6:2022-2031 (Pubitemid 38020768)
9. Emery RW, Krogh CC, Arom KT. The St. Jude Medical cardiac valve prosthesis: A 25-year experience with single valve replacement. Ann Thorac Surg 2005;79:776-785
10. Fernandez J, Laub G, Adkins MS, et al. Early and late-phase events after valve replacement with the St. Jude Medical prosthesis in 1200 patients. J Thorac Cardiovasc Surg 1994;107:394-407 (Pubitemid 24070858)
11. Zellner JL, Kratz JM, Crumbley AJ, et al. Long-term experience with the St. Jude Medical valve prosthesis. Ann Thorac Surg 1999;68:1210-1218
12. Lund O, Nielsen SL, Arildsen H, et al. Standard aortic St. Jude Valve at 18 years: Performance profile and determinants of outcome. Ann Thorac Surg 2000;69:1459-1465 (Pubitemid 30434876)
13. Emery RW, Van Nooten GJ, Tesar PJ. The initial experience with the ATS medical mechanical cardiac valve prosthesis. Ann Thorac Surg 2003;75:444-452 (Pubitemid 36184486)
14. Dumont K, Vierendeels JAM, Segers P, et al. Predicting ATS Open Pivot™ heart valve performance with computational fluid dynamics. J Heart Valve Dis 2005;3:393-399 (Pubitemid 47050754)
15. Nicoloff DM, Friedberg HD, Villafana MA. Is lowintensity anticoagulant therapy possible with an open pivot valve? Analysis of its development. Artif Organs 2002;26:438-443 (Pubitemid 34526487)
16. Emery RW, Krogh CC, Jones DJ, Nicoloff DM, Blake DP, Arom KV. Five-year follow up of the ATS mechanical heart valve. J Heart Valve Dis 2004;2:231-238
17. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-935 (Pubitemid 26301814)
18. Cary, NC. SAS, release 8.02.; SAS Institute, 2001
19. Reul H, van Son, JAM, Steinseifer U, et al. In vitro comparison of bileaflet aortic heart valve prostheses. Cardiovasc Surg 1993;3:412-420
20. Kelly SGD. Computational fluid dynamics insights in the design of mechanical heart valves. Artif Organs 2002;26:608-661
21. Laczkovics A, Heidt M, Oelert H, et al. Early clinical experience with the On-X prosthetic heart valve. J Heart Valve Dis 2001;10:94-99 (Pubitemid 32104471)
22. Jamieson WER, Fradet GJ, Miyagishima RT, et al. CarboMedics mechanical prosthesis: Performance at 8 years. J Heart Valve Dis 2000;9:678-681
23. Tominaga R, Kurisu K, Ochiai Y, et al. A 10-year experience with the CarboMedics cardiac prosthesis. Ann Thorac Surg 2005;79:784-789 (Pubitemid 40288719)
24. Borman JB, De Riberolles C. Sorin Bicarbon™ bileaflet valve: A 10-year experience. Eur J Cardiothorac Surg 2003;23:86-92 (Pubitemid 35472103)
25. Masters RG, Helou J, Pipe AL, Keon WJ. Comparative clinical outcomes with St. Jude Medical, Medtronic Hall and CarboMedics mechanical heart valves. J Heart Valve Dis 2001;10:403-409 (Pubitemid 32454768)
26. Kandemir O, Tokmakoglu H, Yildiz U, et al. St. Jude Medical and CarboMedics mechanical heart valves in the aortic position. Comparison of long-term results. Tex Heart Inst J 2006;33:154-157
27. Laas J, Kseibi S, Perthel M, Klingbeil A, El-Ayoubi L, Aiken A. Impact of high-intensity transient signals on the choice of mechanical aortic valve substitutes. Eur J Cardiothorac Surg 2003;23:93-96 (Pubitemid 35472104)
28. Kofidis T, Fischer S, Leyh R, et al. Clinical relevance of intracranial high intensity transient signals in patients following prosthetic aortic valve replacement. Eur J Cardiothorac Surg 2002;21:22-26 (Pubitemid 34098852)
29. Lindner A, Georgiadis D, Luhmann A, et al. Time course of high-intensity transient signals in patients undergoing elective heart valve replacement: A prospective study. J Heart Valve Dis 1997, 6:527-530 (Pubitemid 27405128)
30. Van Nooten GJ, Van Belleghem Y, Caes F, et al. Lower-intensity anticoagulation for mechanical heart valves: A new concept with the ATS bileaflet aortic valve. J Heart Valve Dis 2003;12:495-501
31. Ageno W, Turpie AGG, Steidl L, et al. Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement Am J Cardiol 2001;88:40-44
32. Turpie AGG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993;329:524-529 (Pubitemid 23232620)
33. Horstkotte D, Bergemann R, Oelert H, Schulte HD, Laas J, Zerkowski HR. Increased acceptance of the International Normalized Ratio (INR) as a monitoring parameter of oral anticoagulation therapy in Germany. GELLA Study Group. Z Kardiol 1998;87:837-843
34. Butchart EG, Gohlke-Barwolf C, Antunes MJ et al. Working Groups on Valvular Heart Disease, Thrombosis, and Cardiac Rehabilitation and Exercise Physiology, European Society of Cardiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J 2005;26:2463-2471